All stock lists
Neurogene Inc. (NASDAQ:NGNE)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
23.54-0.01 (-0.04%)
Insider Score
––Not scored
NGNE Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
NGNE Stock Insider Trading Activity
NGNE stock’s insider trading shows 7 sales on the open market for an estimated $640.00K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| McMinn Rachel CEO | Option exercise | 756 | $25.32 | $19.14K | 0.1% | 1,345,063 | Sep 22, 2026 | — | Form 4 |
| Cvijic Christine Mikail CFO | Sell | 4,200 | $36.13 | $151.76K | 4.8% | 84,040 | Jul 7, 2026 | — | Form 4 |
| Cvijic Christine Mikail CFO | Sell | 600 | $36.02 | $21.61K | 0.7% | 88,240 | Jul 6, 2026 | — | Form 4 |
| Cvijic Christine Mikail CFO | Sell | 1,530 | $35.23 | $53.90K | 1.7% | 88,840 | Jul 2, 2026 | — | Form 4 |
| Cvijic Christine Mikail CFO | Sell | 2,531 | $34.58 | $87.52K | 2.7% | 90,370 | Jul 2, 2026 | — | Form 4 |
| Cvijic Christine Mikail CFO | Sell | 739 | $34.06 | $25.17K | 0.8% | 92,901 | Jul 1, 2026 | — | Form 4 |
| Cvijic Christine Mikail CFO | Sell | 4,800 | $30.07 | $144.35K | 4.6% | 98,440 | May 6, 2026 | — | Form 4 |
| Cvijic Christine Mikail CFO | Sell | 4,800 | $32.44 | $155.69K | 4.9% | 93,640 | May 6, 2026 | — | Form 4 |
| Cvijic Christine Mikail CFO | Sell | 2,558 | $21.62 | $55.32K | 2.4% | 103,240 | Mar 26, 2026 | — | Form 4 |
| McMinn Rachel CEO | Sell | 3,352 | $22.07 | $74.00K | 0.2% | 1,344,307 | Mar 26, 2026 | — | Form 4 |
| Jordan Julie Other | Sell | 828 | $21.89 | $18.13K | 6.2% | 12,472 | Mar 26, 2026 | — | Form 4 |
| Cobb Stuart Other | Sell | 3,991 | $20.41 | $81.46K | 10.7% | 33,303 | Mar 13, 2026 | — | Form 4 |
| Cobb Stuart Other | Sell | 2,658 | $21.34 | $56.72K | 8.0% | 30,645 | Mar 13, 2026 | — | Form 4 |
| Cobb Stuart Other | Sell | 148 | $22.08 | $3.27K | 0.5% | 30,497 | Mar 13, 2026 | — | Form 4 |
| Cvijic Christine Mikail CFO | Sell | 2,387 | $20.42 | $48.75K | 2.2% | 107,456 | Mar 13, 2026 | — | Form 4 |
| Cvijic Christine Mikail CFO | Sell | 1,395 | $21.25 | $29.64K | 1.3% | 106,061 | Mar 13, 2026 | — | Form 4 |
| Cvijic Christine Mikail CFO | Sell | 263 | $22.02 | $5.79K | 0.2% | 105,798 | Mar 13, 2026 | — | Form 4 |
| Cvijic Christine Mikail CFO | Sell | 4,800 | $25.11 | $120.53K | 4.2% | 109,843 | Feb 27, 2026 | — | Form 4 |
| Cobb Stuart Other | Award | 16,500 | — | — | 79.3% | 37,294 | Feb 20, 2026 | — | Form 4 |
| Jordan Julie Other | Award | 4,900 | — | — | 58.3% | 13,300 | Feb 20, 2026 | — | Form 4 |
| Cvijic Christine Mikail CFO | Award | 22,000 | — | — | 23.7% | 114,643 | Feb 20, 2026 | — | Form 4 |
| McMinn Rachel CEO | Award | 25,900 | — | — | 2.0% | 1,347,659 | Feb 20, 2026 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Sell (S) — Open-market or private sale
- Award (A) — Grant or award from the company, not a purchase
- Option exercise (M) — Exercise or conversion of an exempt derivative
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.